Income Statement
COGNITION THERAPEUTICS INC
CGTX
Performance Overview
Click any row in the table to add it to this chart
in millions USD
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Revenue
|
- | - | - | - | - |
|
Cost of Revenue
|
- | - | - | - | - |
|
Gross Profit
|
- | - | - | - | - |
|
Operating Expenses
|
47.80 | 53.97 | 50.72 | 43.55 | 28.60 |
|
Research & Development
|
37.19 | 41.68 | 37.20 | 30.32 | 18.57 |
|
Selling, General & Administrative
|
10.61 | 12.29 | 13.53 | 13.23 | 10.03 |
|
Other Operating Expenses
|
- | - | - | - | - |
|
Operating Income
|
-47.80 | -53.97 | -50.72 | -43.55 | -28.60 |
|
Non-Operating Income
|
- | - | - | - | - |
|
Interest Income
|
- | - | - | - | - |
|
Interest Expense
|
- | - | - | - | 0.90 |
|
Other Non-Op Income / Expense
|
24.31 | 20.00 | 24.94 | 22.15 | 16.88 |
|
Income Before Tax
|
- | - | - | - | - |
|
Income Tax Expense
|
- | - | - | - | - |
|
Non-Controlling Interest
|
- | - | - | - | - |
|
Net Income
|
-23.49 | -33.97 | -25.79 | -21.40 | -11.72 |
Supplemental
Per share data, derived & other items — not part of the income statement
in millions USD unless noted
| Metric | Dec 31, 2025 2025 FY | Dec 31, 2024 2024 FY | Dec 31, 2023 2023 FY | Dec 31, 2022 2022 FY | Dec 31, 2021 2021 FY |
|---|---|---|---|---|---|
|
Depreciation & Amortization
|
- | - | - | - | - |
|
EBITDA
|
-47.76 | -53.86 | -50.63 | -43.47 | -28.51 |
|
Earnings Per Share (Basic)
|
-0.32 | -0.86 | -0.86 | -0.91 | -3.13 |
|
Diluted EPS
|
-0.32 | -0.86 | -0.86 | -0.91 | -3.13 |
|
Weighted Average Shares
|
72.77 | 39.73 | 30.03 | 23.64 | 5.19 |
|
Diluted Weighted Avg Shares
|
72.77 | 39.73 | 30.03 | 23.64 | 5.19 |
|
Comprehensive Income
|
-23.49 | -33.78 | -25.78 | -21.40 | -11.73 |